Acciones de scyx nasdaq
Reciba gratis sus datos actualizados y en vivo para SCYNEXIS Inc - Cotización, gráficos, precios, análisis, noticias y pronósticos para SCYX. ¡Entrar Ahora! SCYNEXIS, Inc., a biotechnology company, delivers therapies for the treatment fungal infections in the United States. It is developing its lead product candidate, ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. Which company executives are buying and selling shares of SCYNEXIS (NASDAQ:SCYX) stock? View the most recent insider trading activity for SCYX stock at MarketBeat. SCYNEXIS (NASDAQ:SCYX) Earnings Information. SCYNEXIS last released its earnings results on November 12th, 2019. The reported ($0.21) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.01. SCYNEXIS has generated ($0.49) earnings per share over the last year.
8/7/2019 · SCYNEXIS (NASDAQ:SCYX): Q2 GAAP EPS of -$0.16 beats by $0.03. Revenue of $0.06M in-line (flat Y/Y). Shares +0.9% AH
Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. If, at any time, you are interested in reverting to our default settings, please select Default Setting above. If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com. 12/31/2019 · Cotización e información de índice NASDAQ 100, acciones del NASDAQ 100, evolución del indice NASDAQ 100 Site uses Cookies. This website utilizes cookies and similar technologies for functionality and other purposes including personalization of content. 2/24/1978 · Ingresos de Scynexis Inc (SCYX). Conozca la cuenta de ingresos de la empresa, su beneficio bruto, ingresos netos, etc. View live SCYNEXIS INC chart to track its stock's price action. Find market predictions, SCYX financials and market news. SCYX | Complete SCYNEXIS Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
12/9/2019 · SCYNEXIS (NASDAQ:SCYX) is 17.8% lower postmarket after launching an offering of common stock and warrants. H.C. Wainwright is sole book-runner for the offering. The company expects to grant the underwriter a 30-day greenshoe option to buy up to an additional 15% of shares at the offering terms.
View live SCYNEXIS INC chart to track its stock's price action. Find market predictions, SCYX financials and market news. SCYX | Complete SCYNEXIS Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Patrón Plazo Fiabilidad Nº de velas atrás Hora de la vela; Patrones emergentes: Engulfing Bearish: 1M: Actual: Bullish Hammer: 30: Actual: Patrones completos: Belt
Please note that once you make your selection, it will apply to all future visits to NASDAQ.com. If, at any time, you are interested in reverting to our default settings, please select Default Setting above. If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
Encuentra la cotización más reciente, historial, noticias y otra información vital de SCYNEXIS, Inc. (SCYX) para ayudarte con tus inversiones e intercambios. En Yahoo Finanzas, encontrarás gratis cotizaciones de acciones, noticias actualizadas, recursos de gestión de cartera de valores, datos de mercado internacional, interacción social y tipos hipotecarios que te ayudarán a gestionar tu vida financiera. Real-time trade and investing ideas on SCYNEXIS SCYX from the largest community of traders and investors. 1/1/2020 · SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced the appointment of accomplished business development executive Philippe Tinmouth to its Board of Directors. Mr. What's going on at SCYNEXIS (NASDAQ:SCYX)? View breaking news headlines for SCYX stock from trusted media outlets at MarketBeat. 12/30/2019 · Información financiera sobre las acciones de PayPal Holdings Inc (PYPL), incluyendo precio de las acciones, último cierre, volumen, variación en 1 año, rango intradía, rango de 52 semanas, capitalización bursátil, ingresos, dividendo etc. de PYPL. 11/12/2019 · SCYNEXIS (NASDAQ:SCYX): Q3 GAAP EPS of -$0.15 beats by $0.07. Cash, cash equivalents and short-term investments of $28.1M
Patrón Plazo Fiabilidad Nº de velas atrás Hora de la vela; Patrones emergentes: Engulfing Bearish: 1M: Actual: Bullish Hammer: 30: Actual: Patrones completos: Belt
2/24/1978 · Ingresos de Scynexis Inc (SCYX). Conozca la cuenta de ingresos de la empresa, su beneficio bruto, ingresos netos, etc. View live SCYNEXIS INC chart to track its stock's price action. Find market predictions, SCYX financials and market news. SCYX | Complete SCYNEXIS Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Patrón Plazo Fiabilidad Nº de velas atrás Hora de la vela; Patrones emergentes: Engulfing Bearish: 1M: Actual: Bullish Hammer: 30: Actual: Patrones completos: Belt 11/19/2019 · A look at the shareholders of SCYNEXIS, Inc. (NASDAQ:SCYX) can tell us which group is most powerful. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in smaller companies. Companies that have been privatized tend to have low insider ownership. Visualiza los gráficos y las cotizaciones de bolsa de SCYX más recientes en MSN Dinero. Profundiza con gráficos interactivos y los artículos principales de 8/14/2019 · Marco Taglietti has been the CEO of SCYNEXIS, Inc. (NASDAQ:SCYX) since 2015. This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. After that, we will consider the growth in the business.
Which company executives are buying and selling shares of SCYNEXIS (NASDAQ:SCYX) stock? View the most recent insider trading activity for SCYX stock at MarketBeat. SCYNEXIS (NASDAQ:SCYX) Earnings Information. SCYNEXIS last released its earnings results on November 12th, 2019. The reported ($0.21) EPS for the quarter, topping analysts' consensus estimates of ($0.22) by $0.01. SCYNEXIS has generated ($0.49) earnings per share over the last year. Encontrá toda la información financiera sobre las acciones de Skyworks Solutions SWKS en el NASDAQ en tiempo real. Ingresá e informate. Analyzing SCYNEXIS (NASDAQ:SCYX) stock? View SCYX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. 12/31/2019 · Is SCYNEXIS Inc (SCYX) Going to Burn These Hedge Funds? Is SCYNEXIS Inc (NASDAQ:SCYX) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper Encuentra la cotización más reciente, historial, noticias y otra información vital de SCYNEXIS, Inc. (SCYX) para ayudarte con tus inversiones e intercambios.